Kenneth Glass, Director at Oncternal Therapeutics, holds 204.82K shares in Oncternal Therapeutics (Ticker: ONCT), holds 499.58K shares in First Horizon (Ticker: FHN), holds 0.00 shares in FedEx (Ticker: FDX). Most recently, Kenneth Glass Bought ― shares of Oncternal Therapeutics on Mar 02, 2016 for an estimated value of 26.40K.